<i>Nigella sativa</i> L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.

Imran M, Khan SA, Abida, Alshammari MK, Alkhaldi SM, Alshammari FN, Kamal M, Alam O, Asdaq SMB, Alzahrani AK, Jomah S.

Open source

DOI
10.3390/molecules27092750
Published
2022-04-25
Container
Molecules
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/molecules27092750,
  title = {<i>Nigella sativa</i> L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.},
  author = {Imran M and  Khan SA and  Abida and  Alshammari MK and  Alkhaldi SM and  Alshammari FN and  Kamal M and  Alam O and  Asdaq SMB and  Alzahrani AK and  Jomah S.},
  year = {2022},
  journal = {Molecules},
  doi = {10.3390/molecules27092750},
  url = {https://doi.org/10.3390/molecules27092750}
}

RIS

TY  - JOUR
TI  - <i>Nigella sativa</i> L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.
AU  - Imran M
AU  -  Khan SA
AU  -  Abida
AU  -  Alshammari MK
AU  -  Alkhaldi SM
AU  -  Alshammari FN
AU  -  Kamal M
AU  -  Alam O
AU  -  Asdaq SMB
AU  -  Alzahrani AK
AU  -  Jomah S.
PY  - 2022
JO  - Molecules
DO  - 10.3390/molecules27092750
UR  - https://doi.org/10.3390/molecules27092750
ER  - 

APA

M, I., SA, K., Abida, MK, A., SM, A., FN, A., M, K., O, A., SMB, A., AK, A., & S., J. (2022). <i>Nigella sativa</i> L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.. Molecules. https://doi.org/10.3390/molecules27092750

Source records